Tanezumab (RN-624) is a high-affinity, specific humanized anti-NGF monoclonal antibody (mAb) that inhibits nerve growth factor (NGF) from binding to its p75 and TrkA receptors in the peripheral nervous system. It is utilized in research investigating bot
CAS Number:
[880266-57-9]
Target:
PF 4383119 , RN-624
* VAT and and shipping costs not included. Errors and price changes excepted
